OraSure Technologies | OSUR - Assets


OraSure Technologies reported $403.17M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Agilent USD 12.81B 86M Dec/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Bio Techne USD 2.52B 3.45M Dec/2025
Bio-Rad Laboratories USD 9.79B 786.5M Mar/2026
Bruker USD 6.24B 193.5M Dec/2025
Cerus USD 221.86M 6.67M Dec/2025
Charles River Laboratories USD 7.14B 378.39M Dec/2025
Danaher USD 83.54B 80M Mar/2026
Dentsply International USD 5.23B 200M Mar/2026
Dexcom USD 6.63B 293.4M Mar/2026
Illumina USD 6.56B 85M Mar/2026
Integra LifeSciences USD 3.58B 24.28M Mar/2026
Intuitive Surgical USD 20.11B 347.7M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Mettler Toledo International USD 3.71B 191.18M Dec/2025
Myriad Genetics USD 673.7M 32.9M Mar/2026
OraSure Technologies USD 403.17M 19.93M Dec/2025
Quidel USD 5.63B 140.6M Mar/2026
Repligen USD 2.93B 18.93M Mar/2026
Revvity USD 12B 171.82M Mar/2026
STAAR Surgical USD 451.68M 4.68M Dec/2025
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Trinity Biotech USD 103.71M 4.08M Sep/2025
Waters USD 24.53B 19.45B Mar/2026